The recent challenges of highly contagious COVID‐19, causing respiratory infections: Symptoms, diagnosis, transmission, possible vaccines, animal models, and immunotherapy
Ranjan K. Mohapatra
1
,
Lucia Pintilie
2
,
Venkataramana Kandi
3
,
Ashish K Sarangi
4
,
Debadutta Das
5
,
Raghaba Sahu
6
,
Lina O. Perekhoda
7
1
Department of Chemistry Government College of Engineering Keonjhar Odisha India
|
2
Department of Synthesis of Bioactive Substances and Pharmaceutical Technologies National Institute for Chemical and Pharmaceutical Research and Development Bucharest Romania
|
3
Department of Microbiology Pratima Institute of Medical Sciences Karimnagar Hyderabad India
|
5
Department of Chemistry Sukanti Degree College Subarnapur Odisha India
|
7
Department of medicinal chemistry National University of Pharmacy Kharkiv Ukraine
|
Publication type: Journal Article
Publication date: 2020-07-26
scimago Q2
wos Q2
SJR: 0.689
CiteScore: 5.6
Impact factor: 3.3
ISSN: 17470277, 17470285
PubMed ID:
32654267
Organic Chemistry
Drug Discovery
Biochemistry
Pharmacology
Molecular Medicine
Abstract
COVID-19 is highly contagious pathogenic viral infection initiated from Wuhan seafood wholesale market of China on December 2019 and spread rapidly around the whole world due to onward transmission. This recent outbreak of novel coronavirus (CoV) was believed to be originated from bats and causing respiratory infections such as common cold, dry cough, fever, headache, dyspnea, pneumonia, and finally Severe Acute Respiratory Syndrome (SARS) in humans. For this widespread zoonotic virus, human-to-human transmission has resulted in nearly 83 lakh cases in 213 countries and territories with 4,50,686 deaths as on 19 June 2020. This review presents a report on the origin, transmission, symptoms, diagnosis, possible vaccines, animal models, and immunotherapy for this novel virus and will provide ample references for the researchers toward the ongoing development of therapeutic agents and vaccines and also preventing the spread of this disease.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
1
2
3
|
|
|
Risk Management and Healthcare Policy
3 publications, 3.37%
|
|
|
Health Science Reports
2 publications, 2.25%
|
|
|
Sensors
2 publications, 2.25%
|
|
|
Vaccines
2 publications, 2.25%
|
|
|
Frontiers in Immunology
2 publications, 2.25%
|
|
|
Journal of Saudi Chemical Society
2 publications, 2.25%
|
|
|
Journal of King Saud University - Science
2 publications, 2.25%
|
|
|
Journal of Medical Virology
2 publications, 2.25%
|
|
|
Egyptian Journal of Basic and Applied Sciences
2 publications, 2.25%
|
|
|
Lecture Notes in Networks and Systems
2 publications, 2.25%
|
|
|
Open Medicine (Poland)
2 publications, 2.25%
|
|
|
Healthcare
2 publications, 2.25%
|
|
|
E3S Web of Conferences
1 publication, 1.12%
|
|
|
ChemistrySelect
1 publication, 1.12%
|
|
|
Journal of Public Health Research
1 publication, 1.12%
|
|
|
Encyclopedia
1 publication, 1.12%
|
|
|
Frontiers in Cellular and Infection Microbiology
1 publication, 1.12%
|
|
|
Frontiers in Psychology
1 publication, 1.12%
|
|
|
Psych
1 publication, 1.12%
|
|
|
Geriatrics (Switzerland)
1 publication, 1.12%
|
|
|
European Surgery - Acta Chirurgica Austriaca
1 publication, 1.12%
|
|
|
Archives of Gynecology and Obstetrics
1 publication, 1.12%
|
|
|
Beni-Suef University Journal of Basic and Applied Sciences
1 publication, 1.12%
|
|
|
Biomedical Signal Processing and Control
1 publication, 1.12%
|
|
|
Travel Medicine and Infectious Disease
1 publication, 1.12%
|
|
|
Journal of Physics: Conference Series
1 publication, 1.12%
|
|
|
Diabetes and Metabolic Syndrome: Clinical Research and Reviews
1 publication, 1.12%
|
|
|
Environmental Research
1 publication, 1.12%
|
|
|
Brain and Behavior
1 publication, 1.12%
|
|
|
1
2
3
|
Publishers
|
2
4
6
8
10
12
14
|
|
|
Springer Nature
13 publications, 14.61%
|
|
|
Wiley
12 publications, 13.48%
|
|
|
MDPI
11 publications, 12.36%
|
|
|
Taylor & Francis
9 publications, 10.11%
|
|
|
Elsevier
8 publications, 8.99%
|
|
|
Frontiers Media S.A.
4 publications, 4.49%
|
|
|
King Saud University
4 publications, 4.49%
|
|
|
Walter de Gruyter
4 publications, 4.49%
|
|
|
Institute of Electrical and Electronics Engineers (IEEE)
2 publications, 2.25%
|
|
|
Medknow
2 publications, 2.25%
|
|
|
EDP Sciences
1 publication, 1.12%
|
|
|
SAGE
1 publication, 1.12%
|
|
|
IOP Publishing
1 publication, 1.12%
|
|
|
American Chemical Society (ACS)
1 publication, 1.12%
|
|
|
Institute for Medical Research and Occupational Health
1 publication, 1.12%
|
|
|
World Scientific
1 publication, 1.12%
|
|
|
Korean Society of Obstetrics and Gynecology
1 publication, 1.12%
|
|
|
Hindawi Limited
1 publication, 1.12%
|
|
|
Media Sphere Publishing House
1 publication, 1.12%
|
|
|
Australasian College for Infection Prevention and Control (ACIPC)
1 publication, 1.12%
|
|
|
Cold Spring Harbor Laboratory
1 publication, 1.12%
|
|
|
Jaypee Brothers Medical Publishing
1 publication, 1.12%
|
|
|
Oxford University Press
1 publication, 1.12%
|
|
|
Bentham Science Publishers Ltd.
1 publication, 1.12%
|
|
|
Association for Computing Machinery (ACM)
1 publication, 1.12%
|
|
|
Research Square Platform LLC
1 publication, 1.12%
|
|
|
Mary Ann Liebert
1 publication, 1.12%
|
|
|
2
4
6
8
10
12
14
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
89
Total citations:
89
Citations from 2024:
17
(19.1%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Mohapatra R. K. et al. The recent challenges of highly contagious COVID‐19, causing respiratory infections: Symptoms, diagnosis, transmission, possible vaccines, animal models, and immunotherapy // Chemical Biology and Drug Design. 2020. Vol. 96. No. 5. pp. 1187-1208.
GOST all authors (up to 50)
Copy
Mohapatra R. K., Pintilie L., Kandi V., Sarangi A. K., Das D., Sahu R., Perekhoda L. O. The recent challenges of highly contagious COVID‐19, causing respiratory infections: Symptoms, diagnosis, transmission, possible vaccines, animal models, and immunotherapy // Chemical Biology and Drug Design. 2020. Vol. 96. No. 5. pp. 1187-1208.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1111/cbdd.13761
UR - https://doi.org/10.1111/cbdd.13761
TI - The recent challenges of highly contagious COVID‐19, causing respiratory infections: Symptoms, diagnosis, transmission, possible vaccines, animal models, and immunotherapy
T2 - Chemical Biology and Drug Design
AU - Mohapatra, Ranjan K.
AU - Pintilie, Lucia
AU - Kandi, Venkataramana
AU - Sarangi, Ashish K
AU - Das, Debadutta
AU - Sahu, Raghaba
AU - Perekhoda, Lina O.
PY - 2020
DA - 2020/07/26
PB - Wiley
SP - 1187-1208
IS - 5
VL - 96
PMID - 32654267
SN - 1747-0277
SN - 1747-0285
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2020_Mohapatra,
author = {Ranjan K. Mohapatra and Lucia Pintilie and Venkataramana Kandi and Ashish K Sarangi and Debadutta Das and Raghaba Sahu and Lina O. Perekhoda},
title = {The recent challenges of highly contagious COVID‐19, causing respiratory infections: Symptoms, diagnosis, transmission, possible vaccines, animal models, and immunotherapy},
journal = {Chemical Biology and Drug Design},
year = {2020},
volume = {96},
publisher = {Wiley},
month = {jul},
url = {https://doi.org/10.1111/cbdd.13761},
number = {5},
pages = {1187--1208},
doi = {10.1111/cbdd.13761}
}
Cite this
MLA
Copy
Mohapatra, Ranjan K., et al. “The recent challenges of highly contagious COVID‐19, causing respiratory infections: Symptoms, diagnosis, transmission, possible vaccines, animal models, and immunotherapy.” Chemical Biology and Drug Design, vol. 96, no. 5, Jul. 2020, pp. 1187-1208. https://doi.org/10.1111/cbdd.13761.
Profiles